{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:16:04Z","timestamp":1765545364448,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.ejogrb.2005.12.004","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T13:25:05Z","timestamp":1139405105000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells"],"prefix":"10.1016","volume":"129","author":[{"given":"Elizabeth A.","family":"Kr\u00e4mer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diethelm","family":"Wallwiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred O.","family":"Mueck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2005.12.004_bib1","first-page":"104","article-title":"On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases","volume":"2","author":"Beatson GT","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1056\/NEJM200101253440407","article-title":"Estrogen and the risk of breast cancer","volume":"344","author":"Clemons","year":"2001","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone replacement therapy in the Million Women Study","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib5","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative Randomised Controlled Trial","volume":"291","author":"The Women's Health Initiative Steering Committee","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1210\/edrv-16-5-559","article-title":"Growth factors in breast cancer","volume":"16","author":"Dickson","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0960-0760(01)00186-8","article-title":"Steroid hormone mimics: molecular mechanisms of cell growth and apoptosis in normal and malignant mammary epithelial cells","volume":"80","author":"Rahmean","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib8","series-title":"Bioluminescence and chemoluminescence: current status","first-page":"417","article-title":"ATP tumor chemosensitivity assay","author":"Andreotti","year":"1991"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib9","unstructured":"Cell Death Detection ELISA, Cat. No. 1 544 675, Version 4. Roche Applied Science; September 2003."},{"key":"10.1016\/j.ejogrb.2005.12.004_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrc721","article-title":"Endocrine-responsive breast cancer and strategies for combating resistance","volume":"2","author":"Ali","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0960-0760(95)00215-4","article-title":"Effects of two classes of progestogens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: 1. MCF-7 cell lines","volume":"55","author":"Schoonen","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib12","first-page":"2551","article-title":"Effect of progestin treatment on estradiol- and growth factor-stimulated breast cancer cell lines","volume":"15","author":"Cappelletti","year":"1995","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-2003-39061","article-title":"The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells","volume":"35","author":"Seeger","year":"2003","journal-title":"Horm Met Res"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/cmt.6.3.221.227","article-title":"Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition","volume":"6","author":"Mueck","year":"2004","journal-title":"Climacteric"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib15","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<758::AID-IJC9>3.0.CO;2-R","article-title":"Hormone replacement therapy and the risk of breast cancer. Nested case\u2013control study in a cohort of Swedish women attending mammography screening","volume":"72","author":"Persson","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib16","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/bjc.1991.178","article-title":"Combined oral contraceptives containing chlormadinone acetate and breast cancer: results of a case\u2013control study","volume":"63","author":"Ebeling","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ijc.2910340514","article-title":"Oral contraceptives containing chlormadinone acetate and cancer incidence at selected sites in the German Democratic Republic\u2014a correlation analysis","volume":"34","author":"Nischan","year":"1984","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T","article-title":"Cancer incidence and mortality in women receiving estrogen and estrogen\u2013progestin replacement therapy\u2014long-term follow-up of a Swedish cohort","volume":"67","author":"Persson","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<169::AID-CNCR24>3.0.CO;2-1","article-title":"Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins","volume":"79","author":"Katsuki","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/gye.16.2.113.120","article-title":"Testosterone and 5 alpha-dihydrotestosterone inhibit in-vitro growth of human breast cancer cell lines","volume":"16","author":"Ortmann","year":"2002","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0378-5122(94)90129-5","article-title":"Plasma concentrations of medroxyprogesterone acetate, estradiol and estrone following oral administration of Klimaxil\u00ae, Trisequence\u00ae\/Provera\u00ae, and Divina\u00ae, a randomised, single-blind, triple cross-over bioavailability study in menopausal women","volume":"18","author":"Svensson","year":"1994","journal-title":"Maturitas"},{"key":"10.1016\/j.ejogrb.2005.12.004_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0010-7824(78)90046-X","article-title":"A radioimmunoassay for norethindrone (NET): measurement of serum net concentrations following ingestion of NET-containing oral contraceptive steroids","volume":"18","author":"Stanczyk","year":"1978","journal-title":"Contraception"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211506000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211506000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:15:50Z","timestamp":1759554950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211506000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0301211506000030"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.12.004","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}